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Abstract This study examined the Health Belief Model’s
efficacy to predict intention to undergo genetic testing for
the Colorectal Carcinoma (CRC) gene within a rural/
frontier setting. Survey data were collected on 558
Southwest Montanan residents. Regression analysis
revealed that perceived benefits, including affordability
and satisfying curiosity, were the strongest indicators of
intention to undergo genetic testing for CRC. Select
consumer barriers and cues to action variables were also
found to be significant predictors. Collectively the model
explained approximately 36% of the variance. These
preliminary findings have implications for genetic counselors,
health practitioners and health care providers concerned with
genetic counseling and addressing the public health issue of
CRC.
Keywords Colorectal cancer screening . Predicting genetic
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Introduction
Cancer is the second leading cause of death in the United
States; in 2006 cancer accounted for one in every four
deaths (American Cancer Society 2006). The direct and
indirect costs of cancer are estimated to be 200 billion
dollars per year. Therefore, cancer is a significant health
issue and needs to be addressed. Colorectal Carcinoma
(CRC) is the third most common cancer found in men and
women in this country. The American Cancer Society
estimated that there would be about 106,680 new cases of
colon cancer and 41,930 new cases of rectal cancer in 2006
in the United States. Combined, these cancers were
expected to account for approximately 55,170 deaths.
Genetic testing, if used, has the potential to enhance
individual health and well-being (U.S. Department of
Health and Human Services and National Cancer
Institute 2007). Some tests are used to clarify a diagnosis
and direct a physician toward appropriate treatments.
Genetic tests can also be used to identify individuals
who are at risk for preventable diseases. Finally, genetic
testing can be used as a powerful diagnostic tool that has
many benefits to the consumer. For example, if an
individual tests positive for a gene mutation, enhanced
screening protocols can be initiated so that tumors can be
identified early in their development, and thus increase
one’s chances for survival. Applications such as this could
potentially prevent thousands of cancer deaths a year.
However, consumers’ decisions to be tested are idiosyn-
cratic and difficult to understand. If health care providers
are to help clients make informed decisions about testing,
they need insight into the factors that are important to their
client’s decision making process. Consequently, explana-
tory theories need to be devised and evaluated to
understand the idiosyncratic processes associated with
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the decision to be tested for gene mutations associated
with conditions such as CRC. The purpose of this study
was to examine the efficacy of the Health Belief Model
(HBM) to predict intention to undergo genetic testing for
the gene mutations associated with CRC within a rural/
frontier setting.
Background
The public health burden of colorectal cancer is substantial
(American Cancer Society 2006; Bunn et al. 2002).
Twenty-five percent of individuals who have a family
history of CRC also have a genetic mutation. While the
actual proportion of individuals who have CRC due to
genetic mutations is low, genetic mutations have been
identified as a cause of inherited CRC risk. Knowledge
about cancer genetics is rapidly expanding, with implica-
tions for all aspects of cancer management, including
prevention, testing, and treatment.
Genetic Causes of Colon and Rectal Cancer
Genes associated with a higher risk of CRC are rare.
However, these inherited gene alterations can increase a
carrier’s risk of acquiring CRC by as much as 90%. The
two main genetic syndromes that have been isolated for
CRC are FAP and HNPCC (Frank et al. 2004 ; Ho et al.
2003). The adenomatous polyposis coli (APC) gene has
been linked to familial adenomatous polyposis or more
commonly known as FAP (American Cancer Society 2006).
The APC gene is normally responsible for slowing down
the growth of cells; when there is a change in this gene the
outcome is FAP or Gardner syndrome. In addition, a
defective DNA repair mechanism gene (i.e., MSH2,
MLH1, PMS1, PMS2, MSH3, and MSH6) is responsible
for hereditary nonpolyposis CRC (HNPCC). Mutations in
the DNA repair enzyme genes in HNPCC allow DNA
errors to go uncorrected, and these errors will sometimes
affect growth-regulating genes, possibly leading to the
development of CRC.
Genetic Testing
There are potential benefits to genetic testing, whether a
person receives a positive or a negative result (U.S.
Department of Health and Human Services and National
Cancer Institute 2007). As mentioned previously, some
tests are used to clarify a diagnosis and direct a physician
toward appropriate treatments. Some genetic tests allow
families to avoid having children with devastating diseases.
Also, tests can be used to identify individuals who are at
risk for preventable diseases. In short, genetic testing, if
used properly could be a powerful diagnostic tool with
potential implications for both symptomatic and asymp-
tomatic individuals.
The potential benefits of a negative result include a sense
of relief and elimination of the need for special preventive
checkups, tests, or surgeries such as annual colonoscopy (a
procedure that allows a physician to view the upper reaches
of the large intestine), which are routine for high-risk
families at risk for CRC (U.S. Department of Health and
Human Services and National Cancer Institute 2007). A
positive test result can bring relief from uncertainty and
allow people to make informed decisions about their future,
including taking steps to reduce cancer risk. When colon
cancer tumors are found early, chances for survival are
greatest, and screening potentially could prevent thousands
of cancer deaths. A positive gene test can encourage
individuals to maintain regular screening practices (annual
colonoscopies to check for precancerous polyps or the
earliest signs of cancer) and to maintain healthful lifestyle
measures such as a high-fiber, low-fat diet and regular
exercise.
One obstacle that genetic counselors and other health
professionals face especially with individuals who could
potentially benefit from the procedure, is the reluctance of
individuals to undergo genetic testing for a predisposition
such as CRC (Ramsey et al. 2003). Consumers are
influenced by a wide combination of factors that could
influence their decision to undergo genetic screening
including financial, emotional, familial pressure, religious,
social and other motivational concerns. Educating genetic
counselors and other health professionals about the cogni-
tive, motivational and emotional factors that influence
decision making processes would enable them to better
understand their clients and thus be more helpful when they
make decisions about testing. In other words, by better
understanding what is important to the client, the practi-
tioner can better facilitate more thoughtful decision making
on the part of the client.
Therefore, there is an immediate need to find the best
predictors of different populations’ decisions to undergo
genetic testing for health risk factors such as CRC. The
Health Belief Model was used in this study in an attempt to
better understand the barriers, benefits, and cues to action
that clients face when making a decision to undergo genetic
testing for the predisposition for CRC.
Health Belief Model
The Health Belief Model (HBM), displayed in Fig. 1, has
been used extensively to predict health behaviors. The
model was initially developed to explain the widespread
failure of individuals to participate in programs to prevent
and detect disease (Strecher and Rosenstock 1997). Over
the last fifty years the HBM has been one of the most
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widely used conceptual frameworks to guide health
programming and research.
The HBM considers the individual’s personal percep-
tions of susceptibility, seriousness, cues to action, personal
demographic variables (gender, age, socioeconomic status,
education and knowledge), and benefits and barriers
regarding a disease (Fig. 1). Collectively the components
may predict an individual’s course of action. The compo-
nents as described by Janz et al. (2002) include: the
perceived susceptibility and perceived severity of a disease
(together defined as perceived threat), perceived benefits of
preventative action, and perceived barriers to a preventative
action. Cues to actions can also serve as prompts to engage
in a preventive action. Some researchers use all of the
components of the HBM while others only use select
components of the model that are most relevant to a given
intervention. In this study the researchers utilized percep-
tions of susceptibility, benefits, barriers, cues to action, and
select personal demographic variables.
HBM and Genetic Testing for CRC
The HBM model has been used in the past to predict the
decision to take preventative screening actions for individ-
ual health (Bunn et al. 2002; Hartman 2002). Some
researchers (Bunn et al. 2002; Ho et al. 2003) have recently
initiated work using the HBM to predict consumers’
intention to undergo a genetic test for CRC. The inves-
tigators in both of these studies collected their data within
an urban setting. However, no published investigations
have used the HBM to explain intention to seek genetic
screening for CRC in rural and frontier settings. Individuals
in rural and frontier settings are often medically under-
served and less research is dedicated to this population
when compared to their urban counterparts. Therefore,
there is a need for further research to specifically research
this underserved population.
Methods
Overview
An exploratory investigation was conducted to examine the
associations between the intention to engage in genetic
testing for CRC (dependent variable) and the independent
variables of interest (components of the HBM). The
research procedures and methods for collecting data were
approved by the Montana State University Human Subjects
Committee in October of 2006. Because survey respond-
ents were not identified in the data collection process, the
use of an informed consent was not needed. To conduct this
investigation the following major steps were initiated:
1. In-depth interviews were conducted on a sample from the
target population of Southwest Montana residents to help
with the development of the HBM mail-out survey.
2. Based on the interviews and past research, the
dependent and independent variable questions were
created for the HBM mail-out survey.
3. After the HBM mail-out survey was developed, a
piloting process was conducted using concurrent and
retrospective interviews.
4. Once finalized, the HBM mail-out surveys were sent
via the U.S. Postal Service to 1,120 randomly selected
individuals within rural/frontier settings. Of the 1,120
addresses, 1,020 of the addresses were valid and
represented the final sample for the mailing.
Fig. 1 Health Belief Model
(HBM). Note. Figure Taken
from Janz et al. (2002, p. 52).
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5. The returned surveys were entered, cleaned and
analyzed using descriptive statistics and regression
analysis.
Sample and Procedures
The investigators desired a sample of individuals from
rural and frontier settings because the vast majority of
Montana counties are rural and frontier. Based on Office
of management and Budget criteria, frontier sites are
defined as counties that have 6 or fewer individuals per
square mile and rural sites are counties with more than
six and fewer than fifty individuals per square mile.
Urban areas have more than 50 individuals per square
mile. Montana has 45 counties classified as frontier, ten
as rural, and one as urban. To this end Butte, MT (Silver
Bow county) was selected as the rural location and
Livingston, MT (Park County) was selected as the
frontier location because they were both located in
Southwest Montana. Five-hundred-ten surveys were
randomly distributed to residents of each county.
The surveys were distributed based on approaches
suggested by Dillman (2000). First, a pre-notification letter
describing the study was mailed to all recipients selected
for the investigation. After correcting for inaccurate
addresses obtained through the original mailing list, a
survey, cover letter, one dollar incentive and pre-addressed
stamped return envelope were mailed to the recipients. The
cover letter explained that the survey was being conducted
to increase awareness of genetic testing for CRC. In order
for the results to be random, we asked that the resident who
was at least 18 years of age who permanently lived in the
house, and most recently had a birthday, complete the
survey. One week after the survey mailing a reminder post
card was mailed thanking those who returned the survey
and encouraging those who had not to do so as soon as
possible.
Instrumentation
In-Depth Interviews
In-depth interview questions were designed to gather
opinions and beliefs about genetic testing for CRC from a
sample of the targeted population of rural and frontier
Montanans. The development of these interview questions
was informed by the work of Bunn et al. (2002) and Ho et
al. (2003). Relevant questions concerning the HBM
components from these researchers’ surveys were used in
the development of interview questions used in this
investigation. In short, the components of the HBM
(perceived susceptibility, benefits, barriers, and cues to
action) guided the creation of open-ended questions
(questions that allow for diverse responses) to measure
engagement behaviors for genetic testing (Bunn et al. 2002;
Hartman 2002; Ho et al. 2003). Hartman (2002) provided a
detailed account of her interview questions and procedures
for examining breast cancer screenings in rural Montana.
Information from this study provided considerable guidance
for the research team because of the population and topic
similarities.
The interviews were conducted on a convenience sample
of 15 Southwest Montana residents after they provided
signed consent. Conversational interviewing and probing
techniques were used to develop a consistent interaction
between the interviewee and interviewer (Babbie 2002).
Before initiating the interviews, the first author who has
received graduate level training in interviewing techniques,
presented basic information about CRC, the gene mutations
associated with CRC, and genetic testing (Ramsey et al.
2003). Next, the interviewees were told about the patterns
and risks associated with the genetic mutations including
both FAP and HNPCC. The open-ended interview ques-
tions displayed in Fig. 2 generated feedback about the
interviewees’ beliefs, attitudes, knowledge, barriers, con-
cerns, and influencing factors related to the issue of having
genetic testing for gene mutations associated with CRC.
The interviews were recorded verbatim and content
analysis was used to identify the general trends and themes
as they related to the HBM. The general trends and themes
gathered from these interviews were applied to the
development of questions for the HBM mail-out survey.
Specifically, the trends and themes were put into categories
based on the components of the HBM (Bunn et al. 2002;
Hartman 2002; Ho et al. 2003). These categories included
overall genetic testing knowledge, benefits, barriers, sus-
ceptibility, and cues to action. The results of the in-depth
interviews and questions generated through past research
contributed to the development of the HBM mail-out
survey questions which are described in detail in the
following section.
Dependent and Independent Variables
The dependent and independent variables were created
based on the in-depth interviews as well as past research
surveys involving the HBM (Bunn et al. 2002; Hartman
2002; Ho et al. 2003). The dependent variable was based on
responses to the question, “If genetic testing for cancer risks
were available to you now, would you be likely to get
tested in the next six months?”
The independent variables of interest included the HBM
components and were measured with questions related to
perceived susceptibility, benefits, barriers, cues to action,
and personal demographics. An example of perceived
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susceptibility was generated by asking the respondent if s/
he had a blood relative with CRC. An example of perceived
benefits was generated by asking the respondent if s/he
would be tested to satisfy curiosity or to encourage a
lifestyle change. Examples of perceived barrier questions
included asking the respondents if they would have
psychological, emotional or financial concerns associated
with CRC testing. Finally, cues to action questioning
included items related to the influence a physician or health
care provider might have on the respondents’ decision to
engaging in genetic testing for CRC.
Personal demographic variables addressed current health
insurance status, number of dependents, marital status, level
of education, income, race, and age. Previous literature has
consistently suggested health care and insurance coverage
broadly affect the decision to be genetically tested (Bosompra
et al. 2000; Church 2006; Keefer 1999; Peterson 2005).
Also, personal and demographic variables tend to be strong
predictors of health behaviors (Green and Kreuter 1999) and
therefore should be included in the analysis.
Survey Pilot
Prior to piloting the HBM mail-out survey a panel of experts
in survey design, genetics and modeling health behaviors
reviewed the questions for accuracy, flow, organization and
design. Next, the survey was piloted using a convenience
sample of ten individuals from a rural Southwest Montana
location. To ensure readability and clarity of the survey, both
concurrent and retrospective interviewing techniques were
used. A concurrent interviewing technique (think-aloud
technique) calls for respondents to formulate their thoughts
into words while completing the survey. In contrast, a
retrospective interviewing technique uses probing questions
asked after the respondent has completed the survey (Dillman
2000). The purpose of the pilot for this study was to
determine whether the respondents understood the questions,
found the layout easy to follow and the delivery of the
survey appealing. Survey revisions were made based on the
information collected from the pilot participants and the
HBM mail-out survey was reviewed again by the same
expert panel and finalized prior to distribution.
Survey Construction and Distribution
The finalized paper and pencil mail-out survey consists of
34 items, divided into two sections: (1) HBM components
and (2) personal demographic questions. Most questions
use a Likert-type scale, with behavioral anchors such as
strongly agree, agree, strongly disagree, disagree, or neither
disagree or agree (Babbie 2002). Other questions were
structured using yes/no, fill in the blank, or checklists
consisting of response categories specific to a given
question (e.g., income brackets).
Data Analyses
Descriptive statistics and regression analysis were used to
determine the efficacy of the Health Belief Model as a
predictor of intention to undergo genetic testing for CRC.
Descriptive statistics were used to describe the character-
istics of the sample. Regression analyses were used to
identify the best predictors for intention to engage in
genetic testing for CRC based on the HBM. Since the
Attitudes, Beliefs, and knowledge about 
genetic testing 
Concerns regarding the barriers 
surrounding genetic testing 
Factors influencing the 
decision 
5.  How would you rate your 
susceptibility to contracting CRC?  
What makes you more or less 
susceptible? 
8.  Who would influence you 
in making the decision to 
undergo genetic testing for 
CRC? 
6.  Has your primary physician ever 
talked to you about having a genetic 
test for CRC or any other cancer? 
9.  What other factors would 
influence your decision to 
undergo genetic testing? 
7.  How would you encourage a 
family member to be genetically 
tested for CRC? 
10.  Is there anything else that 
you would like to talk about
related to CRC? 
1.  When you hear the word genetic testing, 
what comes to mind? 
2.  What are the benefits or positive 
attributes of having a genetic test for the 
gene mutation for CRC? 
3.  What are the barriers or negative 
attributes that might be associated with 
having a genetic test for the gene mutation
associated with CRC? 
4.  What is your primary source(s) for 
receiving information about medical 
decisions? 
Fig. 2 Questions for In-Depth
Interviews.
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dependent variable was binary (intention to test or not to
test), a logistic regression was conducted. The individual
items (questions) associated with each component were
coded as a yes/no response so all of these variables were
coded as dummy variables. Specifically, on the Likert-scale
questions (where the answers were 1=yes, I strongly agree;
2=yes, I agree; 3=no, I disagree; 4=no, I strongly disagree; 5=I
neither agree nor disagree; and 6=I don’t know), 1 and 2 were
coded as yes (1) and all other answers were coded as no (0).
On the other questions (where the answers were 1=yes, 2=no,
3=I don’t know), 1 was coded as yes and all other answers
were coded as no. And finally, on the testing question 1 and 2
were coded as yes (1) and all other answers are coded as no
(0). Two by two tables were used to report screening behaviors
based on key HBM components that were instrumental in
determining the decision making process.
Results
Sample Characteristics
One thousand twenty surveys were distributed and approx-
imately 55% of recipients responded (n=558). The
respondents were comprised of 219 women and 339 men
(Table 1). Ninety-five percent were white, 63% were
married, and slightly over half of the sample had incomes
less than $50 K. Sixty-one percent of the respondents were
between the ages of 36 and 64. Sixty-percent had no
dependents, 84% reported having health care coverage, and
31% had four or more years of college. Overall, 58% of the
respondents indicated they would have a genetic test to
detect their cancer risk in the next six months if it was made
available to them.
The survey respondents were similar demographically to
the populations of Silver Bow and Park Counties with a
few exceptions. Specifically, the HBM survey sample was
somewhat older and better-educated. The sample had a
slightly higher percentage of minority respondents com-
pared to minorities in the Park County population, and a
lower percentage of minority respondents compared to
minorities in Silver Bow County. The sample had a lower
percentage of females than in the population of either Park
or Silver Bow counties.
Reponses to Other Survey Items and Reported Likelihood
to Pursue Genetic Testing
Table 2 contains a summary of the percentage of respondents
who would/would not pursue genetic testing broken down by
their responses (yes/no) to survey items concerning the HBM
components. For example, under cues to action, the item
asking about “prior knowledge of genetic testing” revealed
that 37% (n=51) of the 137 respondents who answered “no”
indicated that they would not be tested, and 43% (n=181) of
the 421 respondents that answered “yes” indicated they
would be genetically tested. For each HBM component item,
confidence intervals (95% level of confidence) were exam-
ined to determine whether there were statistically significant
differences in the percentages of respondents who would
pursue genetic versus those who would not pursue testing. In
the following sections, only those items found to be
statistically significant at a 95% level of confidence are
described.
Table 1 Characteristics of Respondents to the CRC Genetic Testing
Survey (N=558)
Variable n %
Dependent Variable:
Likelihood of having genetic test in next six months
Yes 232 41.6
No 326 58.4
Demographic Variables:
Ages of respondent
35 and younger 49 8.8
36–64 338 60.6
65 and older 171 30.7
Race of respondent
Minority 26 4.7
Non-minority 532 95.3
Gender of respondent
Female 219 39.2
Male 339 60.8
Income
Less than $10,000–14,999 73 13.1
$15,000–$24,999 80 14.3
$25,000–$49,999 140 25.1
$50,000–$99,999 165 29.6
Over $100,000 100 17.9
Marital Status
Divorced, Separated, Never Married 207 37.1
Married, or coupled 351 62.9
Number of Dependents
None 336 60.2
1 or more 222 39.8
Health Insurance Coverage
Yes 471 84.4
No 87 15.6
Education Level
Grades 1–8 (elementary) 15 2.7
Grades 9–11 (some high school) 29 5.2
Grade 12 or GED 149 26.7
College 1–3 years (some college) 184 33.0
College (4 years or more with degree) 171 30.6
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Cues to Action
Three items assessing the cues to action component were
significant at the 95% level of confidence. Forty-six percent
of the 344 respondents who said their physician or primary
health care provider had discussed early detection of CRC
with them intended to pursue genetic testing compared to
34% of the 214 respondents who had not received this
Table 2 Comparisons of Responses to HBM Component Items and
Reported Likelihood of Pursuing CRC Genetic Testing in the Next Six
Months
Would test Would not test
HBM component items n % n %
Prior Knowledge of genetic testing
No (n=137) 51/137 37 86/137 63
Yes (n=421) 181/421 43 240/421 57
Physician or other health care Professional has discussed genetic
testing about CRC
No (n=524) 215/524 41 309/524 59
Yes (n=34) 11/34 32 23/34 68
Physician or other health care Professional has discussed early
detection for CRCa
No (n=214) 73/214 34 141/214 66
Yes (n=344) 158/344 46 186/344 54
Have read or heard about genetic testing
No (n=515) 211/515 41 304/515 59
Yes (n=43) 19/43 44 24/43 56
A family member would influence their decision to be genetically
tested
No (n=323) 136/323 42 187/323 58
Yes (n=235) 94/235 40 141/235 60
A physician would influence their decision to be genetically testeda
No (n=58) 13/58 22 45/58 78
Yes (n=500) 220/500 44 280/500 56
A health care professional would influence their decision to be
genetically testeda
No (n=227) 82/227 36 145/227 64
Yes (n=331) 149/331 45 182/331 55
Perceived Susceptibility
Blood relative with CRCa
No (n=475) 185/475 39 290/475 61
Yes (n=81) 46/81 57 35/81 43
Likelihood to get CRC in your lifetimea
No (n=535) 193/535 36 342/535 64
Yes (n=23) 13/23 57 10/23 43
Nutritional Habits
No (n=506) 202/506 40 304/506 60
Yes (n=50) 26/50 52 24/50 48
Exercise Habits
No (n=514) 211/514 41 303/514 59
Yes (n=40) 21/40 53 19/40 47
Smoking Habitsa
No (n=513) 205/513 40 308/513 60
Yes (n=39) 25/39 64 14/39 36
Perceived Benefits
Family could benefit from the information of a genetic testa
No (n=169) 24/169 14 145/169 86
Yes (n=389) 206/389 53 183/389 47
Table 2 (continued)
Would test Would not test
HBM component items n % n %
Family could make better decision about their own healtha
No (n=147) 22/147 15 125/147 85
Yes (n=411) 189/411 46 222/411 54
Could encourage a lifestyle changea
No (n=72) 12/72 17 60/72 83
Yes (n=486) 199/486 41 287/486 59
Decrease chance of surgerya
No (n=331) 106/331 32 225/331 68
Yes (n=227) 125/227 55 102/227 45
Satisfy curiositya
No (n=304) 61/304 20 243/304 80
Yes (n=254) 173/254 68 81/254 32
Perceived Barriers
Large financial impact on myself or my familya
No (n=219) 72/219 33 147/219 67
Yes (n=339) 159/339 47 180/339 53
Results could be an obstacle to getting/keeping health insurance
No (n=281) 107/281 38 174/281 62
Yes (n-277) 125/277 45 152/277 55
Health insurance coverage would be an obstacle to getting a genetic
test
No (n=348) 143/348 41 205/348 59
Yes (n=210) 88/210 42 122/210 58
Having a genetic test would cost too much money
No (n=389) 167/389 43 222/389 57
Yes (n=169) 64/169 38 105/169 62
Would have a genetic test if it would cost $100 or lessa
No (n=278) 58/278 21 220/278 79
Yes (n=280) 190/280 68 90/280 32
Would have a genetic test if it would cost $1,000 or lessa
No (n=512) 195/512 38 317/512 62
Yes (n=46) 35/46 76 11/46 24
Respondents answered the HBM components described as yes/no
responses and their decision to engage in genetic testing based on the
yes/no responses’ classification based on each HBM item. Some HBM
components had missing values and therefore the number of
observations may vary across items.
a Statistically significant at the 95% level of confidence.
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feedback. Forty-four percent of the 500 respondents who
said their physician would influence their decision reported
they would pursue testing, compared to the 22% of the 58
respondents who did not regard their physician as influ-
encing their decision. Forty-five percent of the 331
respondents who said another health professional would
influence their decision reportedly would undergo genetic
testing compared to 36% of the 227 respondents who did
not perceive another health professional as being influential.
Perceived Susceptibility
Three items assessing the susceptibility component were
significant at the 95% level of confidence. Fifty-seven
percent of the 81 respondents who indicated they had a
blood relative who had or currently has CRC also reported
they would pursue genetic testing in the next six months
compared to 39% of the 475 respondents who did not have
an affected blood relative. Fifty-seven percent of the 23
respondents who perceived themselves as likely to contract
CRC in their lifetime indicated an intention to be
genetically tested in the next six months, compared to
36% of the 535 respondents who did not think view
themselves as likely to contract CRC. Sixty-four percent of
the 39 respondents who indicated their smoking habits put
them at an increased their risk of developing CRC reported
they would pursue genetic testing compared to 40% of the
513 respondents who indicated their smoking habits did not
place them at an increased risk.
Perceived Benefits
Every item assessing the benefit component was significant
at the 95% level of confidence. Fifty-three percent of the
389 respondents who indicated their family could receive
useful health information from the results of their genetic
test for CRC also reported they would be genetically tested
in the next six months compared to only 14% of the 169
respondents who feel it would not be useful information for
their family. Forty-six percent of the 411 respondents who
indicted their family members could make better decision
about their health also indicated they would be tested,
compared to only 15% of the 147 respondents that did not
think it would help family members make decisions. Forty-
one percent of the 486 respondents who indicated the
results from their genetic test would encourage a change in
their lifestyle also reported they would be tested, compared
to 17% of the 72 respondents who did not feel it would
encourage a lifestyle change. Fifty-five percent of the 227
respondents who reported the genetic test for CRC would
decrease their chances of requiring radical surgery also
indicated they would pursue testing, compared to 32% of
the 331 who did not think it would decrease their chance
for surgery. Sixty-eight percent of the 254 respondents who
indicated they would participate in a genetic test for CRC to
satisfy their curiosity also reported they would pursue the
test, compared to 20% of the 304 respondents who did not
think the test would satisfy their curiosity.
Perceived Barriers
Three items assessing the barriers component were
significant at the 95% level of confidence. Forty-seven
percent of the 339 respondents who believed that a high
risk classification for CRC through genetic testing would
likely have a large financial impact on themselves or
their family also reported they would pursue the test,
compared to 33% of the 219 respondents who believed it
would not have a large financial impact. Sixty-eight
percent of the 280 respondents who said they would
participate in a genetic test if their actual out of pocket
cost was less than one-hundred dollars also said they
would pursue genetic testing in the next six months,
compared to 21% of the 278 respondents who would not
participate in a genetic test costing less than one-hundred
dollars. Seventy-six percent of the 46 respondents who
said they would participate in a genetic test if their actual
out of pocket cost was less than one-thousand dollars
also indicated they would pursue testing in the next six
months, compared to 38% of the 512 respondents who
would not participate in genetic testing costing less than
one-thousand dollars.
Regression Analyses
The survey data were analyzed using two different series of
logistic regression analyses. One series of regression
analyses was run using component specific items for each
component of the HBM (cues to action, perceived
susceptibility, perceived benefits and barriers) to identify
the likelihood of respondents undergoing genetic testing in
the next 6 months (Table 3). In short, the regressions were
used to identify what component items were significantly
related to testing while holding constant the influence of
other items associated with that component. For example,
the influence of a physician discussing early detection
could be evaluated while holding constant the influence of
other cue to action component factors such as prior
knowledge, discussing CRC with a physician, etc. There-
fore, a total of four separate regressions that included all of
the component items for each component were conducted.
These regressions allowed the researchers to measure the
impact of each component separately.
The second regression analyses included the component
items for all four HBM components. This was a more
sophisticated analysis since each item could be examined
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while holding constant the influence of all other items
associated with the entire HBM (Table 4). Both of these
series of regression analyses showed the HBM component
of perceived benefits to be the most influential predictor of
respondents’ decision to be tested for CRC in the next
6 months.
Individual Component Item Regression
Table 3 displays the regression analyses of the individual
HBM components. Significance for the model and the item
measures (independent variables of interest) within each
component were tested for significance at an alpha level of
p≤ .05.
The HBM component of cues to action explained
approximately 4% of the variance associated with genetic
testing intention. The two items within the cues to action
component that were significant included: physician dis-
cussed early detection for CRC with them, and a physician
would influence a respondents’ decision to be genetically
tested.
Perceived susceptibility explained approximately 5% of
the variance associated with genetic testing intention. The
three items within the susceptibility component that were
Characteristics Parameter
estimate
Standard
error
p-value
Intercept −1.6462 0.3726 0.0000*
Cues to Action
Prior knowledge of genetic testing 0.1798 0.2076 0.3864
Physician discussed genetic testing for CRC 0.2702 0.3791 0.4761
Physician discussed early detection for CRC 0.4209 0.1872 0.0246*
Read/heard about genetic testing in the media 0.0041 0.3409 0.9904
A family member would influence decision to be genetically tested −0.0495 0.1798 0.7831
A physician would influence decision to be genetically tested 0.8054 0.3383 0.0173*
A health care professional would influence decision to be genetically tested 0.2930 0.1872 0.1176
Cox and Snell R-squared 0.0360
Intercept −0.5842 0.1046 0.0000*
Perceived Susceptibility
Blood relative with CRC 0.6317 0.2526 0.0124*
Likelihood of CRC in lifetime 1.4312 0.5287 0.0068*
Nutritional habits 0.0654 0.3638 0.8573
Exercise habits 0.3827 0.3919 0.3289
Smoking habits 0.9989 0.3544 0.0048*
Cox and Snell R-squared 0.0500
Intercept −3.0552 0.4155 0.0000*
Perceived Benefits
Beneficial information for family 1.0892 0.3294 0.0009*
Family could make better decisions 0.5208 0.3560 0.1435
Encourage lifestyle change 0.4506 0.3976 0.2570
Decrease chance of surgery 0.4063 0.2112 0.0544*
Satisfy curiosity 1.8159 0.2073 0.0000*
Cox and Snell R-squared 0.2830
Intercept −1.5413 0.2041 0.0000
Perceived Barriers
Large impact on family 0.3183 0.2143 0.1374
Obstacle to getting/keeping insurance 0.3249 0.2133 0.1277
Concern for job security −0.3160 0.2969 0.2872
Health insurance coverage would be an obstacle to genetic testing 0.0289 0.2188 0.8948
Cost too much money −0.4555 0.2286 0.0463*
Cost me less than $100 1.6854 0.1987 0.0000*
Cost me less than $1,000 1.2514 0.3937 0.0015*
Cox and Snell R-squared 0.1910
Table 3 Logistic Regression
Analyses Examining the
Influence of Individual HBM
Components (Cues to Action,
Perceived Susceptibility,
Benefits and Barriers) on the
Likelihood to Undergo Genetic
Testing in the Next 6 Months
*Significant at p≤ .05
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significant included: having a blood relative who has/had
CRC, respondents’ belief that they could contract CRC in
their lifetime, and a belief that their smoking habits would
increase their risk of contracting CRC.
Perceived benefits explained approximately 28% of the
variance associated with intention to be tested for CRC in
the next 6 months. The three items within the benefits
component that were significant included: providing useful
information for their family members, a decreased chance
of surgery, and satisfying their own curiosity.
Perceived barriers explained approximately 19% of the
variance associated with intention to be tested. Three items
within the barrier component that were significant were
financial, including if the test cost too much money, and if
it costs less than $100, or $1,000; all were associated with
increased intention to engage in genetic testing.
Characteristics Parameter
estimate
Standard
error
p-value
Intercept −5.0919 1.1272 0.0000
Cues to Action
Prior knowledge of genetic testing 0.3403 0.2947 0.2482
Physician discussed genetic testing for CRC 0.3862 0.5102 0.4491
Physician discussed early detection for CRC 0.0648 0.2678 0.8087
Read/heard about genetic testing in the media −0.4644 0.4710 0.3241
A family member would influence decision to be genetically tested 0.1611 0.2358 0.4945
A physician would influence decision to be genetically tested 0.2625 0.4369 0.5479
A health care professional would influence decision to be genetically tested 0.3005 0.2460 0.2220
Perceived Susceptibility
Blood relative with CRC 0.3990 0.3246 0.2189
Likelihood of CRC in lifetime 1.0677 0.7249 0.1408
Nutritional habits −0.6137 0.4424 0.1654
Exercise habits 0.6429 0.4952 0.1942
Smoking habits 0.6363 0.4191 0.1289
Perceived Benefits
Beneficial information for family 1.1182 0.3705 0.0025*
Family could make better decisions 0.4159 0.3890 0.2850
Encourage lifestyle change 0.4215 0.4381 0.3359
Decrease chance of surgery 0.4295 0.2391 0.0725
Satisfy curiosity 1.5106 0.2467 0.0000*
Perceived Barriers
Large impact on family 0.2022 0.2588 0.4346
Obstacle to getting/keeping insurance 0.1027 0.2569 0.6894
concern for job security −0.1945 0.3622 0.5913
Health insurance coverage would be an obstacle to genetic testing −0.0801 0.2630 0.7606
Cost too much money −0.2291 0.2731 0.4017
Cost me less than $100 0.8556 0.2501 0.0006*
Cost me less than $1,000 0.7966 0.4583 0.0822
Personal and Demographic
Health insurance status 0.6782 0.3532 0.0548
Gender 0.2596 0.2559 0.3103
Marital status −0.1740 0.2709 0.5207
Number of dependents −0.2211 0.2700 0.4129
Race −0.9912 0.5550 0.0741
Age 0.3884 0.1960 0.0475*
Income 0.0033 0.0048 0.4907
Education −0.0104 0.0123 0.3993
Cox and Snell R-squared 0.3570
Table 4 Regression Analyses
of the Influences of the
Composite HBM Components
on the Likelihood to be
Genetically Tested for CRC in
the Next Six Months
*Significant p≤ .05
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Four Component HBM Item Regression
Table 4 displays the four component HBM regression
analysis for all items related to each of the HBM
components. Janz et al. (2002) recommended that when
investigators use the HBM they include the individual items
associated with each component, (e.g., perceived suscepti-
bility, benefits, barriers, etc.). They made this recommen-
dation because the analysis can provide more precise
information that would allow practitioners to more accurately
apply the findings to a given health enhancement effort.
Based on this recommendation, the present researchers
included each item associated with the four HBM compo-
nents in the regression analysis rather than developing a
composite score for each component.
The regression analysis showed that the composite HBM
with all components accounted for approximately 36% of
the variance for intention to engage in genetic testing for
CRC in the next six months (Table 4). None of the cues to
action or perceived susceptibility component items were
found to be significant predictors of genetic testing
intention. One demographic variable (age) was significant
in this model. Older respondents were more likely to
indicate an intention to pursue testing. Perceptions that test
results would be beneficial to respondents’ family and that
they would satisfy the respondents’ curiosity both signifi-
cantly increased reported likelihood of pursuing testing.
Finally, the barrier item of having costs less than $100
significantly increased the likelihood that the respondents
would pursue testing.
Two-By-Two Tables
The two-by-two tables shown in Table 5 were developed by
first generating composite scores by summing responses to
all the items within a given component. Next, a median
split was conducted for each component to develop a high
(values above the median) and low (values below the
median) scores. Based on the high low classifications,
calculations were made so that the percentage of respond-
ents who intended to be tested for CRC in the next six
months could be reported in the two-by-two tables. Since
the regression analyses revealed that benefit items were the
strongest predictor of testing intention, all components were
compared to the benefit component.
The results support the strong association between the
benefits component and the dependent variable of likelihood
to be genetically tested in the next six months. The benefits
and barriers comparisons revealed 44% of respondents
intended to undergo genetic testing when barriers were low
and benefits were high. However, when barriers and benefits
were high, 63% of the respondents intended to be tested. This
is the one pair that does not follow the expected pattern. Two-
by-two tables can be an effective method for succinctly
displaying complex concepts. However, this simplified
depiction will occasionally produce inconsistent patterns.
Nevertheless, the other seven pairs showed a consistent
pattern. For instance, when benefits were low and barriers
were high, 9% of the respondents intended to be tested.
Similarly, when benefits were low and barriers were low, only
14% of the respondents intended to be tested. The dramatic
and consistent pattern was also found for cues to action and
susceptibility. For example, when cues and benefits were high
55% of the respondents intended to be tested. However when
benefits were low and cues were low, only 9% reported an
intention to be tested.
Discussion
The Health Belief Model has been used to predict health
behavior over the past fifty years in urban, rural and frontier
settings. This study examined the Health Belief Model’s
(HBM) efficacy for predicting intention to undergo genetic
testing for the Colorectal Carcinoma (CRC) gene within a
Table 5 Percentage of Respondents Reporting Intention to be Tested
by Perceived Benefits Perceived Barriers, Cues to Action and
Perceived Susceptibility
Barriers
High Low
Benefits
High 63% 44%
Low 9% 14%
Cues to Action
High Low
Benefits
High 55% 50%
Low 14% 9%
Susceptibility
High Low
Benefits
High 67% 53%
Low 50% 12%
The two-by-two comparisons shown in this table were developed
by first generating composite scores by summing the scores of all
items within a given component. Next, a median split was
conducted for each component to develop a high (values above
the median) and low (values below the median) scores. Based on the
high/low classifications, calculations were made so that the
percentage of respondents who intended to be tested for CRC in
the next six months could be reported in the two-by-two tables.
Because the regression analyses revealed that benefit items were the
strongest predictor of testing intention, All components were
compared to the benefit component.
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rural and frontier setting. Collectively, the analysis revealed
that perceived benefits were the best indicators of intention
to undergo genetic testing for CRC during the next
6 months. Other HBM component items were also found
to be significant predictors such as perceived barriers,
susceptibility and cues to action. Collectively the model
explained approximately 36% of the variance in intention to
pursue genetic testing. These preliminary findings have
implications for genetic counselors and other health practi-
tioners concerned with addressing the public health issue of
genetic testing for CRC in a rural and frontier area.
For instance, the majority of the respondents (approxi-
mately 59%) indicated that they intended to be genetically
tested for CRC in the next 6 months. However, a sizable
percentage (41%) did not intend to pursue testing. In order
for counselors and other health practitioners to better assist
individuals to make appropriate decisions, it is necessary
for practitioners to understand the factors that are most
important in the decision making process. These factors
would include those that encourage (curiosity) and dissuade
(costs) participation.
Bunn et al. (2002) found that the HBM was a good
predictor of urban dwelling adults’ decision to undergo
genetic testing for CRC. The researchers found that
perceived barriers, perceived benefits and perceived sus-
ceptibility had the greatest influence on the likelihood to
engage in genetic testing. Specifically, the respondents
generally agreed that genetic testing for cancer risk would
be a benefit to their families and fewer respondents reported
barriers to testing, with the highest reported barrier being
financial in nature.
The results of the present investigation are congruent
with these findings of Bunn et al. (2002) for the
components of barriers and benefits, but not for suscepti-
bility. In short, susceptibility proved to not be an important
predictor of the intention to be tested for CRC. Consistent
with Bunn et al. (2002), the present findings revealed that
perceptions of testing result as being beneficial to one’s
family was significant. The results from this investigation
also showed that decreasing one’s chance for surgery was
an important factor in all analyses except the four
component regression. To our knowledge, this is the first
study to demonstrate that satisfying one’s curiosity about
his/her own predisposition is a significant and important
predictor of screening intention.
The barrier of costs was a significant predictor of
intention even though many of the respondents were
willing to pay as much as $1,000 to receive the testing
procedure. In other studies not specific to CRC, researchers
have found that cost and insurance coverage are important
predictors of the likelihood to be genetically tested (Gwyn
et al. 2003). The findings of this study provide additional
support that costs are an important determinant for testing
intention. However, there is a need to more precisely
identify how much consumers will actually spend for
genetic testing.
There was some support for the notion that one’s
physician could influence the respondent’s intention to be
tested. However, when all of the components of the HBM
were entered into a single regression, the physician was no
longer a significant cue to action. The results are not
definitive and additional research is needed to clarify the
relationship between testing intention and the physician as
an important cue to action.
There was some support that circumstances (e.g., blood
relative who has/had CRC) and behaviors (e.g., smoking
habits related to perceptions of susceptibility) could
influence the respondent’s intention to be tested. However,
when all of all components of the HBM were entered into a
single regression, the susceptibility items were no longer a
significant. Prior to this study, much of the genetic testing
education has focused on client perceived susceptibility
(Bunn et al. 2002; Helmes et al. 2000; Ho et al. 2003; U.S.
Department of Energy Office of Science, Office of
Biological and Environmental Research, & Program 2004;
U.S. Department of Health and Human Services and
National Cancer Institute 2007). For example, education
has focused on consumers’ likelihood to contract CRC
based on family history, and lifestyle such as diet, exercise
or smoking habits. However, based on the present findings
for a rural/frontier sample, it appears that these factors
would not be the primary focus of an educational campaign.
One concern with the present analysis involves the
wording of the lifestyle habits (i.e., nutrition, exercise and
smoking). In these questions respondents were asked
whether their exercise, nutrition and smoking habits
influenced their risk for CRC. The assumption was that
favorable habits reduced risk (e.g., non-smokers would
have a lower risk). However, respondents were not asked
about their actual exercise, nutritional and smoking habits.
Having this information might have altered the results if
respondents equated poor nutrition, sedentary lifestyles and
smoking with decreased risk for health. These counter-
intuitive assumptions on the part of respondents are not
likely, but it is an issue future researchers should address in
subsequent studies.
Conclusion
Further research is needed to more definitively clarify the
determinants of intention to be genetically tested for CRC
and better guide counselors and health practitioners in their
intervention efforts. Use of the HBM to guide future
investigations is warranted in that the constructs derived
from the model helped the present researchers identify
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specific items that were strong predictors of intention for
genetic testing. In total, the model explained 36% of the
variance. Specifically, this study showed that perceived
barriers and benefits directly influenced the intention to be
tested—especially the benefit of satisfying ones curiosity,
obtaining beneficial information for one’s family members,
and appropriate pricing of the test. These findings have
direct implications for designing educational strategies to
improve decision-making concerning genetic testing for
CRC risk in the rural and frontier population. Provision of
information/education remains a vital tool for genetic
counselors and other health care providers when addressing
their patients’decisions to participate in genetic testing for
any cancer risk. However, it also is important for practi-
tioners to assess the cognitive, motivational and emotional
factors that are important in a given patient’s decision
making process in order to help them make informed
decisions. The findings from this preliminary study can be
useful in this regard.
As more research is conducted to identify the factors that
influence decision making, researchers and practitioners
should thoroughly consider how this information may be
best used. In this study the sampling was directed to the
general population within rural and frontier settings. Should
research efforts be directed solely to individuals who are at
risk? If yes, how might the findings vary based on those
populations? Also, how should the findings from these type
of investigations be used? Specifically, should they be used
to better inform individuals so that they can engage in
reflection and introspection to make informed decisions?
The answers to these questions are beyond the scope of this
paper. However, they are critical as practitioners decide
how to apply the findings from this study and from related
research.
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